NUS Earnings & Financial Statements
Nu Skin Enterprises, Inc.
$5.11
+$0.10(+2.00%)
69
Overall
100
Value
70
Tech
39
Quality
Market Cap
$248.74M
Volume
421.39K
52W Range
$4.45 - $11.67
Target Price
$6.75
NUS earnings and financial statements: Nu Skin Enterprises, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
NUS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.49B | $1.73B | $1.97B | $2.23B | $2.70B |
| Cost of revenue | $453.76M | $550.23M | $611.85M | $630.91M | $675.22M |
| Operating income | $65.76M | -$151.59M | $48.27M | $110.85M | $233.99M |
| EBITDA | $288.63M | -$52.23M | $156.38M | $205.99M | $362.18M |
| Net income | $160.20M | -$146.59M | $8.60M | $104.78M | $147.27M |
| EPS (diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $1.41B | $1.47B | $1.81B | $1.82B | $1.91B |
| Total liabilities | $600.07M | $817.46M | $986.66M | $923.67M | $993.71M |
| Shareholders’ equity | $805.24M | $651.46M | $821.97M | $897.30M | $912.77M |
| Cash and equivalents | $238.63M | $186.88M | $256.06M | $264.73M | $339.59M |
| Long-term debt | $261.83M | $422.05M | $548.98M | $454.01M | $357.54M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $80.29M | $111.74M | $118.64M | $108.06M | $141.58M |
| Capital expenditure | -$34.28M | -$41.58M | -$58.49M | -$59.06M | -$68.61M |
| Free cash flow | $46.01M | $70.16M | $60.15M | $49.01M | $72.97M |
| Dividends paid | $11.80M | $11.90M | $77.60M | $77.00M | $76.30M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NUS | $5.11 | +2.0% | 421.39K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nu Skin Enterprises, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW